S-40503
id:
s-40503-264-5429810
title:
S-40503
text:
S-40503 is an investigational selective androgen receptor modulator (SARM) developed by the Japanese company Kaken Pharmaceuticals, which was developed for the treatment of osteoporosis. SARMs are a new class of drugs which produce tissue-specific anabolic effects in some tissues such as muscle and bone, but without stimulating androgen receptors in other tissues such as in the prostate gland, thus avoiding side effects such as benign prostatic hypertrophy which can occur following treatment wit
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/S-40503
date created:
date modified:
2022-06-19T20:41:30Z
main entity:
{"identifier":"Q7387039","url":"https://www.wikidata.org/entity/Q7387039"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1c/S-40503.svg","width":512,"height":272}
fields total:
13
integrity:
15